Adverum Biotechnologies Inc
(NASDAQ:ADVM)
$1.68
0.13[8.39%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$1.67
-0.0100[-0.60%]
Open1.530Close1.680
Vol / Avg.296.600K / 457.203KMkt Cap169.668M
Day Range1.530 - 1.70052 Wk Range0.535 - 2.340

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Adverum Biotechnologies Stock (NASDAQ:ADVM), Key Statistics

Adverum Biotechnologies Stock (NASDAQ: ADVM) analysis, key statistics.

Valuation Measures
Enterprise Value
119.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
43.11
Price / Book (mrq)
1.19
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-85.81%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.3
Tangible Book value per share
1.3
Total Liabilities (Quarterly)
110.3M
Total Assets
241.4M
Total Liabilities
110.3M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -